Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19

Addie B Spier; Colin E Evans

doi:10.1016/j.tru.2020.100028

Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19

Thromb Update. 2021:2:100028. doi: 10.1016/j.tru.2020.100028. Epub 2021 Mar 19.

Authors

Addie B Spier¹, Colin E Evans^{2

3}

Affiliations

¹ Department of Medicine, University of Illinois College of Medicine, Rockford, IL, USA.
² Lung and Vascular Biology Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
³ Department of Pediatrics, Division of Critical Care, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Abstract

The 2019-2020 COVID-19 outbreak resulted in widespread suffering along with major changes in the ways that researchers carry out their work. This article profiles the experiences of an early-career investigator in thrombosis research who worked through the COVID-19 pandemic and a COVID-19 diagnosis. The aims of this article are to normalize concern regarding COVID-19 in the research community, to provide a perspective on maintaining productivity during stay-at-home periods, and to discuss how the COVID-19 pandemic might alter common research practices in the future. While the COVID-19 outbreak was clearly disruptive and debilitating on a global level, some research practices that were heavily employed during the pandemic may continue to be utilized in scientific research for many years to come.

Keywords: COVID-19; Research; Sepsis.